Patrick Daly

Patrick Daly is a contributing writer for GU Oncology Now. He is an assistant editor for DocWire News with several years of experience in producing multimedia content for B2B and B2C audiences in the financial and health care industries.

Articles by Patrick Daly

Patrick DalySUO 2022 | December 2, 2022
Increasing BMI in prostate cancer was associated with Gleason Grade Group 3 and pT3 stage PZ tumors and larger TZ tumors.
Read More
Patrick DalySUO 2022 | December 2, 2022
18F-rhPSMA-7.3 showed high sensitivity for detecting pelvic lymph node metastases in newly diagnosed prostate cancer.
Patrick DalySUO 2022 | December 2, 2022
Researchers found baseline testosterone levels had no significant impact on relugolix treatment outcomes in prostate cancer.
Patrick DalySUO 2022 | December 2, 2022
Outpatient RARP showed significant cost savings and patient satisfaction and safety comparable with inpatient procedures.
Patrick DalySUO 2022 | December 2, 2022
Up to 11% of patients had incontinence 1 year after radical prostatectomy, but salvage treatment rate was low, study finds.
Patrick DalySUO 2022 | December 2, 2022
Androgen deprivation therapy for prostate cancer may be associated with increased risks for neurocognitive disorders.
Patrick DalySUO 2022 | December 2, 2022
Only a small proportion of patients with prostate cancer recurrence received follow-up salvage treatment, according to data.
Patrick DalySUO 2022 | December 2, 2022
Weight gain and obesity were correlated with more cardiovascular and all-cause mortality, but not prostate cancer survival.
Patrick DalySUO 2022 | November 30, 2022
Patients who recovered from postprostatectomy incontinence started physical therapy earlier than patients who did not.
Patrick DalySUO 2022 | November 30, 2022
A study suggested patients with prostate cancer on active surveillance could benefit from additional systematic biopsies.